Publication

Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease

Dias, F., Teixeira, A. L., Nogueira, I., Morais, M., Maia, J., Bodo, C., Ferreira, M., Silva, A., Vilhena, M., Lobo, J., Sequeira, J. P., Maurício, J., Oliveira, J., Kok, K., Costa-Silva, B. & Medeiros, R., 2-Jun-2020, In : Cancers. 12, 6, 17 p., 1450.

Research output: Contribution to journalArticleAcademicpeer-review

  • Francisca Dias
  • Ana Luísa Teixeira
  • Inês Nogueira
  • Mariana Morais
  • Joana Maia
  • Cristian Bodo
  • Marta Ferreira
  • Alexandra Silva
  • Manuela Vilhena
  • João Lobo
  • José Pedro Sequeira
  • Joaquina Maurício
  • Jorge Oliveira
  • Klaas Kok
  • Bruno Costa-Silva
  • Rui Medeiros

Clear cell renal cell carcinoma (ccRCC) is the most aggressive subtype of kidney cancer and up to 40% of patients submitted to surgery with a curative intent will relapse. Thus, the aim of this study was to analyze the applicability of an Extracellular vesicle (EV) derived miRNA profile as potential prognosis biomarkers in ccRCC patients. We analyzed a nine-miRNA profile in plasma EVs from 32 ccRCC patients with localized disease (before and after surgery) and in 37 patients with metastatic disease. We observed that the levels of EV-derived hsa-miR-25-3p, hsa-miR-126-5p, hsa-miR-200c-3p, and hsa-miR-301a-3p decreased after surgery, whereas hsa-miR-1293 EV-levels increased. Furthermore, metastatic patients presented higher levels of hsa-miR-301a-3p and lower levels of hsa-miR-1293 when compared to patients with localized disease after surgery. Functional enrichment analysis of the targets of the four miRNAs that decreased after surgery resulted in an enrichment of terms related to cell cycle, proliferation, and metabolism, suggesting that EV-miRNA enrichment in the presence of the tumor could represent an epigenetic mechanism to sustain tumor development. Taken together, these results suggest that EVs content varies depending on the presence or absence of the disease and that an increase of EV-derived hsa-miR-301a-3p, and decrease of EV-derived hsa-miR-1293, may be potential biomarkers of metastatic ccRCC.

Original languageEnglish
Article number1450
Number of pages17
JournalCancers
Volume12
Issue number6
Publication statusPublished - 2-Jun-2020

Download statistics

No data available

ID: 136287744